Five Presentations Will Highlight Findings from the XIPERE® Pivotal Phase 3 Program VAUGHAN, ON, July 6, 2022 — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global …
Tag:
retina
-
-
Survey Reinforces Need for Innovative Therapies, Including Options Administered Through Suprachoroidal Space VAUGHAN, ON, May 12, 2022 — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global …